Intralesional interferon alfa-2b for refractory, recurrent squamous cell carcinoma of the face.
Department of Dermatology, Section of Cutaneous Oncology and Dermatologic Surgery, Yale University School of Medicine, New Haven, Connecticut. Electronic address: allison.hanlon@yale.edu.
Allison
A
Hanlon
June
J
Kim
David J
DJ
Leffell
D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D005153:Facial Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D015552:Injections, Intralesional; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage*; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000008:administration & dosage; D012878:Skin Neoplasms / Q000188:drug therapy*
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins